Importer of Controlled Substances Registration, 42696 [2018-18266]
Download as PDF
<![CDATA[
42696
Federal Register / Vol. 83, No. 164 / Thursday, August 23, 2018 / Notices
Dated: August 17, 2018.
Uttam Dhillon,
Acting Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
[FR Doc. 2018–18265 Filed 8–22–18; 8:45 am]
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
SUMMARY:
Company
FR docket
Fisher Clinical Services, Inc ..........................................................................................
Unither Manufacturing LLC ............................................................................................
83 FR 28663 ......................
83 FR 29136 ......................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrants to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: August 17, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–18266 Filed 8–22–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
daltland on DSKBBV9HB2PROD with NOTICES
Greg N. Rampey, D.O.; Dismissal of
Proceedings
On October 27, 2017, the Acting
Assistant Administrator, Diversion
Control Division, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Greg N. Rampey, D.O.
(Registrant), of Tulsa, Oklahoma. The
Show Cause Order proposed the
revocation of Registrant’s DEA
Certificate of Registration No.
BR7006085 on the ground that he has
VerDate Sep<11>2014
19:43 Aug 22, 2018
Jkt 244001
‘‘no state authority to handle controlled
substances’’ in the State of Oklahoma,
the State in which he is registered with
the DEA. Order to Show Cause,
Government Exhibit (GX) 2, at 1, 2
(citing 21 U.S.C. 824(a)(3)). For the same
reason, the Order also proposed the
denial of any of Registrant’s
‘‘applications for renewal or
modification of such registration and
any applications for any other DEA
registrations.’’ Id. at 1.
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Registrant is the holder of
Certificate of Registration No.
BR7006085, pursuant to which he is
authorized to dispense controlled
substances as a practitioner in schedules
II through V, at the registered address of
8596 E. 101st, Ste. B, Tulsa, Oklahoma.
Id. The Order also alleged that this
registration does not expire until April
30, 2018. Id.
As the substantive ground for the
proceeding, the Show Cause Order
alleged that ‘‘on September 21, 2017, the
Oklahoma State Board of Osteopathic
Examiners cancelled [Registrant’s]
osteopathic medical license’’ and his
‘‘Oklahoma Bureau of Narcotics and
Dangerous Drugs registration is
inactive.’’ Id. at 1–2. The Show Cause
Order thus alleged that Registrant is
‘‘currently without authority to practice
medicine or handle controlled
substances in the State of Oklahoma, the
[S]tate in which [he is] registered with
the DEA,’’ and that, as a consequence,
‘‘DEA must revoke’’ his registration. Id.
at 2.
The Show Cause Order notified
Registrant of (1) his right to request a
hearing on the allegations or to submit
a written statement in lieu of a hearing,
(2) the procedure for electing either
option, and (3) the consequence for
failing to elect either option. Id. (citing
21 CFR 1301.43). The Order also
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Published
June 20, 2018.
June 22, 2018.
notified Registrant of his right to submit
a corrective action plan. Id. at 2–3
(citing 21 U.S.C. 824(c)(2)(C)).
According to an Affidavit of Service
filed in this matter, on October 30, 2017,
personnel from DEA’s Office of Chief
Counsel, Diversion and Regulatory
Litigation Section, attempted to serve
the Show Cause Order on the Registrant
by regular first class mail addressed to
the Registrant at his registered address.
GX 6. The Government represents that
its mailing was not returned as
undeliverable. Id. On January 10, 2018,
the Government submitted a Request for
Final Agency Action (RFAA)
representing that Registrant did not
request a hearing and ‘‘ha[d] not filed
any written statement in lieu of a
hearing’’ within 30 days of service and
seeking a final order revoking his
registration. GX 7, at 2.
On February 6, 2018, the then-Acting
Administrator issued an Order noting
that the Government’s effort at service
in this case was ‘‘a departure from the
Agency’s traditional practice.’’ GX 8.
The Order further noted that ‘‘the
Government cites to no authority
establishing that a sole effort of mailing
by first class mail (with no evidence of
delivery to the address) is sufficient to
provide constitutionally adequate
service for initiating a proceeding under
the Due Process Clause.’’ Id. As a result,
the then-Acting Administrator directed
the Government to either address why
its effort was consistent with the Due
Process Clause or to engage in
additional reasonable efforts to serve
Registrant. Id.
On March 29, 2018, my office
received the Government’s Second
Request for Final Agency Action
(SRFAA) describing a Diversion
Investigator’s additional attempts to
serve the Show Cause Order and again
seeking a final order revoking
Registrant’s registration. SRFAA, at 2.
E:\FR\FM\23AUN1.SGM
23AUN1
]]>Agencies
[Federal Register Volume 83, Number 164 (Thursday, August 23, 2018)]
[Notices]
[Page 42696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18266]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
Fisher Clinical Services, Inc.... 83 FR 28663....... June 20, 2018.
Unither Manufacturing LLC........ 83 FR 29136....... June 22, 2018.
------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of the listed registrants to import the applicable basic
classes of schedule I or II controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each company's maintenance of effective
controls against diversion by inspecting and testing each company's
physical security systems, verifying each company's compliance with
state and local laws, and reviewing each company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed companies.
Dated: August 17, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-18266 Filed 8-22-18; 8:45 am]
BILLING CODE 4410-09-P
